首页> 外文OA文献 >Potential Future Clinical Applications for the GPIIb/IIIa Antagonist, Abciximab in Thrombosis, Vascular and Oncological Indications

【2h】

Potential Future Clinical Applications for the GPIIb/IIIa Antagonist, Abciximab in Thrombosis, Vascular and Oncological Indications

机译：GpIIb / IIIa拮抗剂，阿昔单抗在血栓形成，血管和肿瘤适应症中的潜在未来临床应用

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Sidney A Cohen; Mohit Trikha; Mary A Mascelli;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Potential future clinical applications for the GPIIb/IIIa antagonist, abciximab in thrombosis, vascular and oncological indications [J] . Mary A. Mascelli, Mohit Trikha, Sidney A. Cohen Pathology oncology research: POR . 2000,第3期

机译：GPIIb / IIIa拮抗剂，阿昔单抗在血栓形成，血管和肿瘤适应症中的潜在未来临床应用
2. Comparative antiplatelet efficacy of a novel, nonpeptide GPIIb/IIIa antagonist (XV454) and abciximab (c7E3) in flow models of thrombosis. [J] . Abulencia JP, Tien N, McCarty OJ, Arteriosclerosis, thrombosis, and vascular biology . 2001,第1期

机译：新型非肽GPIIb / IIIa拮抗剂（XV454）和abciximab（c7E3）在血栓形成的血流模型中的比较抗血小板功效。
3. Novel technetium-99m-labeled platelet GPIIb/IIIa receptor antagonists as potential imaging agents for venous and arterial thrombosis. [J] . Mousa SA, Bozarth JM, Edwards S, Coronary artery disease . 1998,第2a3期

机译：新型tech 99m标记的血小板GPIIb / IIIa受体拮抗剂可作为静脉和动脉血栓形成的潜在显像剂。
4. DETECTION OF DEEP VENOUS THROMBOSIS IN AN EXPERIMENTAL ANIMAL MODEL USING RADIOACTIVE LABELLED TIROFIBAN-GPIIb/IIIa INHIBITOR [C] . E. JANEVIK-IVANOVSKA, I. DJORGOSKI, A. ANDONOVSKI, Trends in Radiopharmaceuticals(ISTR-2005) . 2007

机译：放射性标记的替罗非班-GPIIb / IIIa抑制剂在实验动物模型中检测深静脉血栓形成
5. Antiphospholipid antibodies and platelet hyperreactivity as markers for thrombosis of the hemodialysis vascular access: A correlative clinical study. [D] . El-Choufani, Samer E. 2006

机译：抗磷脂抗体和血小板高反应性作为血液透析血管通路血栓形成的标志物：一项相关的临床研究。
6. IQCA-TAVV: To explore the effect of P-selectin GPIIb/IIIa IL-2 IL-6 and IL-8 on deep venous thrombosis [O] . Jianhui Wu, Haimei Zhu, Guodong Yang, 2017

机译：IQCA-TAVV：探讨P-选择蛋白GPIIb / IIIaIL-2IL-6和IL-8对深静脉血栓形成的影响
7. Comparative Antiplatelet Efficacy of a Novel, Nonpeptide GPIIb/IIIa Antagonist (XV454) and Abciximab (c7E3) in Flow Models of Thrombosis [O] . James P. Abulencia, Niven Tien, Owen J. T. McCarty, 2001

机译：一种新型，非肽GPIIB / IIIa拮抗剂（XV454）和Abciximab（C7E3）在血栓形成的模型中的比较抗血小板疗效

Potential Future Clinical Applications for the GPIIb/IIIa Antagonist, Abciximab in Thrombosis, Vascular and Oncological Indications

著录项

引文网络

相似文献

相关主题

期刊订阅